Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

NCT06505551 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV-Related Squamous Cell Carcinoma
HPV-Related Cervical Squamous Cell Carcinoma
HPV-Related Vulvar Squamous Cell Carcinoma
HPV-Related Penile Squamous Cell Carcinoma
HPV-Related Vaginal Squamous Cell Carcinoma
HPV-Related Anal Squamous Cell Carcinoma
HPV-Related Head and Neck Cancer

Interventions

BIOLOGICAL: SCG142
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

SCG Cell Therapy Pte. Ltd.